SCHEMBL19576752

SCHEMBL19576752

CN(Cc1ccccc1)CC1CCCCC1C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 3/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ SLC18A3 Q16572 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ MAPK1 P28482 1/20 0.41
▸ CTSK P43235 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ CA12 O43570 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ SLC6A4 P31645 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24576787 0.85 TAAR1 (0.47) TAAR1SMN1; SMN2SLC18A3MEN1KMT2A
SCHEMBL24576451 0.85 TAAR1 (0.47) TAAR1SMN1; SMN2SLC18A3MEN1KMT2A
SCHEMBL22415955 0.82 OPRK1 (0.45) SMN1; SMN2MEN1KMT2ARAB9AALDH1A1
SCHEMBL19576648 0.79 TAAR1 (0.44) TAAR1SMN1; SMN2MEN1KMT2ACTSK
SCHEMBL7452644 0.77 TAAR1 (0.53) TAAR1SMN1; SMN2MEN1KMT2ACTSK
SCHEMBL19576639 0.77 PEPD (0.34) TAAR1
SCHEMBL7452648 0.77 TAAR1 (0.53) TAAR1SMN1; SMN2MEN1KMT2ACTSK
SCHEMBL7230439 0.77 TAAR1 (0.53) TAAR1SMN1; SMN2MEN1KMT2ACTSK
SCHEMBL19576744 0.76 TAS2R14 (0.38) SMN1; SMN2KMT2ASLC6A4
SCHEMBL6742208 0.75 TAAR1 (0.40) TAAR1CTSKRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452485-B1 ARGINASE INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS ONCOARENDI THERAPEUTICS SA (PL) 2020-09-09 — — EP disclosed
WO-2017191130-A2 ARGINASE INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS ONCOARENDI THERAPEUTICS SA (PL) 2017-11-09 — — WO disclosed
Send feedback